AAA: Abdominal aortic aneurysm
With rigorous quality standards, QuantaNova provides a clean, consistent, and transparent experience for serious researchers
Anil Makam, M.D., an internal medicine physician at the University of California, San Francisco, notes that GLP-1s may be a future therapeutic option for people with substance use disorders
If you increase dose and change timing simultaneously, you cannot determine which change affected results
While there may be some resistance to the conduction of clinical trials of pharmacological interventions in these clinical populations, the mechanistic profile of GLP-1RAs clearly suggests that these medications may play a role in the treatment of certain specific eating disorders, such as BED